Lead Time and Immortal Time Biases Impact the Calculation of Post-colonoscopy Colorectal Cancer Survival
Clinical Gastroenterology and Hepatology · 2024
DOI: 10.1016/j.cgh.2024.05.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2024. Verfasst von James H-E Kang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Kaiser Permanente Northern California Division of Research, Oakland, California. Electronic address: jameshekang@gmail.com. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Colonoscopy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: NCI NIH HHS, US-UK Fulbright Commission, The Royal Society of Medicine.
Abstract (Originalsprache)
The World Endoscopy Organization (WEO) standardized the reporting of post-colonoscopy colorectal cancers (PCCRCs), which account for 7% to 10% of colorectal cancers (CRCs).1 PCCRCs are diagnosed 6 to 36 months after a false negative colonoscopy. Detected CRCs (dCRCs) are diagnosed ≤6 months after an index true positive colonoscopy.2 PCCRC prognosis is unclear, with outcomes reported as comparable,3 superior,4 or inferior5,6 to those of dCRC. Because WEO terminology defines cases relative to the index colonoscopy, conventional survival analyses of PCCRC are susceptible to lead time and immortal time biases. We evaluated the influence of these biases on mortality in a population-based retrospective cohort of 10,938 dCRCs (93.8%) and 717 PCCRCs (6.2%). This study was set within Kaiser Permanente Northern California (KPNC), a large integrated health system, whose members are similar in demographic and socioeconomic characteristics to the Northern California region.7.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Kaiser Permanente Northern California Division of Research, Oakland, California. Electronic address: jameshekang@gmail.com.
- Kaiser Permanente Northern California Division of Research, Oakland, California.
Förderung
- NCI NIH HHS
- US-UK Fulbright Commission
- The Royal Society of Medicine
- Kaiser Permanente
- National Institutes of Health
Zitieren
APA
Kang, J. H., Jensen, C. D., Merchant, S. A., & Lee, J. K. (2024). Lead Time and Immortal Time Biases Impact the Calculation of Post-colonoscopy Colorectal Cancer Survival. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2024.05.014
Vancouver
Kang JH, Jensen CD, Merchant SA, Lee JK. Lead Time and Immortal Time Biases Impact the Calculation of Post-colonoscopy Colorectal Cancer Survival. Clinical Gastroenterology and Hepatology. 2024. doi:10.1016/j.cgh.2024.05.014
BibTeX
@article{Kang2024,
author = {Kang, James H-E and Jensen, Christopher D and Merchant, Sophie A and Lee, Jeffrey K},
title = {Lead Time and Immortal Time Biases Impact the Calculation of Post-colonoscopy Colorectal Cancer Survival},
journal = {Clinical Gastroenterology and Hepatology},
year = {2024},
doi = {10.1016/j.cgh.2024.05.014}
}
EUVIMED